| Bioactivity | CR-1-30-B is an inactive enantiomer of CR-1-31-B. CR-1-30-B, as a control, is inactive against eIF4A and has no apparent effect on the induction of MUC1-C translation[1]. |
| Name | CR-1-30-B |
| CAS | 1352914-53-4 |
| Formula | C28H29NO8 |
| Molar Mass | 507.53 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen) |
| Reference | [1]. Jin C, et al. Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein [published correction appears in Oncogene. 2021 May;40(18):3347]. Oncogene. 2013;32(17):2179-2188. |
CR-1-30-B
CAS: 1352914-53-4 F: C28H29NO8 W: 507.53
CR-1-30-B is an inactive enantiomer of CR-1-31-B. CR-1-30-B, as a control, is inactive against eIF4A and has no apparent
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.